Metoprolol to Reduce Perioperative Myocardial Injury

Completed · Phase 3 · Has a placebo group

Conditions studied: Heart Diseases

In brief

The purpose of this research study is to test if a commonly used, FDA-approved medication, called metoprolol, given at the conclusion of anesthesia following surgery, and during postoperative admission, reduces the possibility of heart related complications in patients with coronary artery disease (CAD).

Key facts

Study ID
NCT03138603
Run by
University of Chicago
People needed
72
Starts
2016-12-01
Expected to finish
2023-08-29
Last updated by the study team
2026-01-28

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.